本文章的引用
本文章的通讯作者
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (2632)
All Articles published online
|
2008-07-18 (publication date) through 2025-01-30
本文章的被引频次
本文章的期刊信息
出版物名称
世界华人消化杂志
ISSN
1009-3079
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 康凯夫, 王晓蔚, 陈小伍, 石祥呈. Beclin1和NF-κB p65在肝癌中的表达及其临床意义. 世界华人消化杂志 2008; 16(20): 2244-2247 [DOI: 10.11569/wcjd.v16.i20.2244] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v16/i20/2244.htm |
| 编号 | Citing Articles |
| 1 |
Hexiao Tang, Yongde Liao, Guang Chen, Liqiang Xu, Chao Zhang, Sheng Ju, Sheng Zhou. Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β. Medical Oncology 2012; 29(4): 2640 doi: 10.1007/s12032-012-0198-8
|
| 2 |
Hexiao Tang, Yongde Liao, Liqiang Xu, Chao Zhang, Zhaoguo Liu, Yu Deng, Zhixiao Jiang, Shengling Fu, Zhenguang Chen, Sheng Zhou. Estrogen and insulin‐like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice. International Journal of Cancer 2013; 133(10): 2473 doi: 10.1002/ijc.28262
|
| 3 |
Hexiao Tang, Yongde Liao, Chao Zhang, Guang Chen, Liqiang Xu, Zhaoguo Liu, Shengling Fu, Li Yu, Sheng Zhou. Fulvestrant-Mediated Inhibition of Estrogen Receptor Signaling Slows Lung Cancer Progression. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2014; 22(1): 13 doi: 10.3727/096504014X14077751730315
|